Studies uncover cost-effectiveness, safety of drug-coated stents

Drug-coated stents did not raise the risk of death and heart attack in patients compared to bare metal stents, according to a study presented at the American Heart Association's annual meeting Sunday. Meanwhile, results of another study that analyzed costs from earlier research comparing stents and angioplasty surgery, found that stents are not cost-effective in patients with chronic chest pain and did not prolong patients' lives.

View Full Article in:

Boston Globe (tiered subscription model), The · Bloomberg · Yahoo!

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT